Summary
Complete resection (CTR) of meningeal melanocytomas results in better outcome than incomplete resection (ITR). After ITR, outcome is improved by radiotherapy. CTR is less frequent with spinal melanocytomas than with cerebral melanocytomas. This study of 49 spinal melanocytoma patients was performed to define an appropriate radiation dose after ITR.
All reported spinal melanocytoma cases were reviewed for extent of surgery, radiotherapy (total dose, dose per fraction), and outcome. CTR was compared to ITR for local control (LC) and overall survival (OS). ITR alone was compared to ITR plus radiotherapy (ITR + RT). In the ITR + RT group, doses of 50–52.2 Gy (1.8–2.0 Gy per fraction) were compared to doses < 50 Gy (30–45 Gy).
The 5-year LC was 78% after CTR alone vs. 22% after ITR alone (P < 0.001). Five year OS was 83 and 40% (P = 0.011) respectively. ITR + RT was superior to ITR for LC (59% vs. 22%, P = 0.029) and OS (85% vs. 40%, P = 0.10). In the ITR + RT group, 50–52.2 Gy resulted in better LC than 30–45 Gy (100% vs. 33%; P = 0.042), but not in significantly better OS (100% vs. 77%, P = 0.33).
CTR was associated with better significantly outcome than ITR. After ITR, the outcome was significantly improved by radiotherapy, 50–52.2 Gy was significantly superior to 30–45 Gy. To reduce the risk of radiation myelopathy, 50.4 Gy (1.8 Gy per fraction) appears appropriate for most patients. The recurrence rates after CTR would mandate the use of post-operative radiotherapy in all spinal meningeal melanocytoma cases. Our results should be confirmed in a larger series of patients when available.
Similar content being viewed by others
References
Cordoba A, Tunon T, Vazquez JJ, Meningeal melanocytoma. Presentation of a case and review of the literature Arch Neurobiol 52: 93–99, 1989
O’Brien TF, Moran M, Miller JH, Hensley SD, Meningeal melanocytoma. An uncommon diagnostic pitfall in surgical neuropathology Arch Pathol Lab Med 119: 542–546, 1995
De Potter P, Shields CL, Eagle RC, Shields JA, Lipkowitz JL, Malignant melanoma of the optic nerveArch Ophthalmol 114: 608–612, 1996
Barth A, Pizzolato GP, Berney J, Intramedullary meningeal melanocytoma Neurochirurgie 39: 188–194, 1993
Ferracini R, Gardini G, Brisigotti M, Lanzanova G, Manetto V, Lorenzini P, Metastasizing meningeal melanocytomaTumori 66: 405–408, 1980
Rades D, Schild SE, Tatagiba M, Molina HA, Alberti W, Therapy of meningeal melanocytomasCancer 100: 2442–2447, 2004
Limas C, Tio FO, Meningeal melanocytoma (‘melanotic meningioma’). Its melanotic origins revealed by electron microscopy.Cancer 30: 1286–1294, 1972
Kaplan EL, Meier P, Non-parametric estimation from incomplete observationsJ Am Stat Assoc 53: 457–481, 1958
Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, Shank B, Solin LJ, Wesson M, Tolerance of normal tissue to therapeutic irradiationInt J Radiat Oncol Biol Phys 21: 109–122, 1991
Joiner MC, Van der Kogel AJ, 1997, The linear-quadratic approach to fractionation and calculation of isoeffect relationships In: Steel GG, (ed) Basic Clinical Radiobiology. Oxford University PressNew York pp 106–122
Kurita H, Segawa H, Shin M, Ueki K, Ichi S, Sasaki T, Tago M, Kirino T: Radiosurgery of meningeal melanocytomaJ Neuro-Oncol 46: 57–61, 2000
Verma DS, Spitzer S, Legha S, Mc Credie KB, Chemoimmunotherapy for meningeal melanocytoma of the thoracic spinal cord. Report of a caseJAMA 242: 2435–2436, 1979
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rades, D., Schild, S.E. Dose–response relationship for fractionated irradiation in the treatment of spinal meningeal melanocytomas: a review of the literature. J Neurooncol 77, 311–314 (2006). https://doi.org/10.1007/s11060-005-9048-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-005-9048-2